Literature DB >> 23824105

[Late and prolonged pseudoprogression in serial posttreatment MRI due to use of new chemotherapy concepts to treat malignant glioblastoma].

O Ganslandt1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23824105     DOI： 10.1007/s00066-013-0382-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Late and prolonged pseudoprogression in glioblastoma after treatment with lomustine and temozolomide.

Authors:  Moritz Stuplich; Dariusch R Hadizadeh; Klaus Kuchelmeister; Jasmin Scorzin; Christian Filss; Karl-Josef Langen; Niklas Schäfer; Frederic Mack; Heinrich Schüller; Matthias Simon; Martin Glas; Torsten Pietsch; Horst Urbach; Ulrich Herrlinger
Journal:  J Clin Oncol       Date:  2012-06-11       Impact factor: 44.544

2.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.

Authors:  Patrick Y Wen; David R Macdonald; David A Reardon; Timothy F Cloughesy; A Gregory Sorensen; Evanthia Galanis; John Degroot; Wolfgang Wick; Mark R Gilbert; Andrew B Lassman; Christina Tsien; Tom Mikkelsen; Eric T Wong; Marc C Chamberlain; Roger Stupp; Kathleen R Lamborn; Michael A Vogelbaum; Martin J van den Bent; Susan M Chang
Journal:  J Clin Oncol       Date:  2010-03-15       Impact factor: 44.544

3.  Response criteria for phase II studies of supratentorial malignant glioma.

Authors:  D R Macdonald; T L Cascino; S C Schold; J G Cairncross
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.